Waltham, MA · Founded 2017 · Privately Held (backing)
Developer of biotechnology platforms intended for drug discovery and development. Alloy Therapeutics is based in Waltham, MA and was founded in 2017. It was valued at $1 billion at its later-stage round in Apr 2026, the last priced event on record. It has raised $174 million across 3 recorded rounds; the latest was a $30 million early-stage round in Mar 2026.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$174.0M
Last round
Early Stage VC
Mar 2026
No prints on record
No secondary trades in Alloy Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alloy Therapeutics with a free account
·The complete investor list: 24 names
·Watch Alloy Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Alloy Therapeutics stock.
